Skip to main content

RETRACTION article

Front. Oncol., 10 November 2023
Sec. Cancer Molecular Targets and Therapeutics
Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1320477

Retraction: The oncolytic virus in cancer diagnosis and treatment

This article is a retraction of:

  1. RETRACTED: The Oncolytic Virus in Cancer Diagnosis and Treatment

    1. Read original article
Frontiers Editorial Office* Frontiers Editorial Office*

    A Retraction of the Review Article
    The oncolytic virus in cancer diagnosis and treatment

    by Cao G-D, He X-B, Sun Q, Chen S-H, Wan K, Xu X, Feng X-D, Li P-P, Chen B and Xiong M-M (2020) Front. Oncol. 10:1786. doi: 10.3389/fonc.2020.01786

    Following publication, concerns were raised regarding the scientific validity of the article. An investigation was conducted in accordance with Frontiers’ policies. It was found that these concerns were valid and that the article does not meet the standards of editorial and scientific soundness for Frontiers in Oncology; therefore, the article has been retracted.

    This retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor of Frontiers. The authors do not agree to this retraction.

    Citation: Frontiers Editorial Office (2023) Retraction: The oncolytic virus in cancer diagnosis and treatment. Front. Oncol. 13:1320477. doi: 10.3389/fonc.2023.1320477

    Received: 12 October 2023; Accepted: 12 October 2023;
    Published: 10 November 2023.

    Approved by:

    Massimo Broggini, Mario Negri Institute for Pharmacological Research (IRCCS), Italy

    Copyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    *Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.